Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a major cause of death among patients with liver cirrhosis. The rise of immuno‐oncology has revolutionized treatment for advanced HCC. However, most pivotal randomized controlled trials have excluded patients with moderate liver dysfunction (Child–Pugh–Turcotte B),...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Frederico, Wiedenmann, Bertram, Roderburg, Christoph, Mohr, Raphael, Abou‐Alfa, Ghassan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
REVIEWS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358256/
https://www.ncbi.nlm.nih.gov/pubmed/37162288
http://dx.doi.org/10.1002/cam4.6033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358256/
https://www.ncbi.nlm.nih.gov/pubmed/37162288
http://dx.doi.org/10.1002/cam4.6033

Ejemplares similares